MedTrace Logo

Effect of an Anti-Oxidant Treatment on Resistin Serum Levels.A Randomized Study

NCT00387114 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2006-10-12

No results posted yet for this study

Summary

The aim of the present study was to evaluate whether an in vivo treatment with an antioxidant vitamin (vitamin C) might substantially affect serum levels of resistin, a recently described adipokine, whose clinical significance is still controversial in humans.

Conditions

Interventions

DRUG

Vitamin C

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Gianfranco Pagano, MD · University of Turin, Italy

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30
Completion
2005-11-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00387114 on ClinicalTrials.gov